Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate FDA reform bill slated for Labor Committee markup June 4.

This article was originally published in The Tan Sheet

Executive Summary

NATIONAL UNIFORMITY PROVISION IN DEVELOPMENT FOR SENATE FDA REFORM BILL, according to a recently circulated Labor & Human Resources Committee summary of the draft bill. The summary notes that "several product categories regulated by FDA are potentially subject to state laws which can...undermine interstate commerce and second guess FDA's authority." The proposal to address the problem is "under development," the summary states.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087134

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel